Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Metagenomics Market, by Workflow
1.4.2 Europe Metagenomics Market, by Product
1.4.3 Europe Metagenomics Market, by Technology
1.4.4 Europe Metagenomics Market, by Application
1.4.5 Europe Metagenomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Metagenomics Market
Chapter 4. Europe Metagenomics Market by Workflow
4.1 Europe Sequencing Market by Country
4.2 Europe Pre-sequencing Market by Country
4.3 Europe Data Analysis Market by Country
Chapter 5. Europe Metagenomics Market by Product
5.1 Europe Kits & Reagents Market by Country
5.2 Europe Sequencing & Data Analytics Services Market by Country
5.3 Europe Software Market by Country
Chapter 6. Europe Metagenomics Market by Technology
6.1 Europe Shotgun Sequencing Market by Country
6.2 Europe 16S Sequencing Market by Country
6.3 Europe Whole Genome Sequencing Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Metagenomics Market by Application
7.1 Europe Environmental Market by Country
7.2 Europe Clinical Diagnostics Market by Country
7.3 Europe Drug Discovery Market by Country
7.4 Europe Biotechnology Market by Country
7.5 Europe Food & Nutrition Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Metagenomics Market by Country
8.1 Germany Metagenomics Market
8.1.1 Germany Metagenomics Market by Workflow
8.1.2 Germany Metagenomics Market by Product
8.1.3 Germany Metagenomics Market by Technology
8.1.4 Germany Metagenomics Market by Application
8.2 UK Metagenomics Market
8.2.1 UK Metagenomics Market by Workflow
8.2.2 UK Metagenomics Market by Product
8.2.3 UK Metagenomics Market by Technology
8.2.4 UK Metagenomics Market by Application
8.3 France Metagenomics Market
8.3.1 France Metagenomics Market by Workflow
8.3.2 France Metagenomics Market by Product
8.3.3 France Metagenomics Market by Technology
8.3.4 France Metagenomics Market by Application
8.4 Russia Metagenomics Market
8.4.1 Russia Metagenomics Market by Workflow
8.4.2 Russia Metagenomics Market by Product
8.4.3 Russia Metagenomics Market by Technology
8.4.4 Russia Metagenomics Market by Application
8.5 Spain Metagenomics Market
8.5.1 Spain Metagenomics Market by Workflow
8.5.2 Spain Metagenomics Market by Product
8.5.3 Spain Metagenomics Market by Technology
8.5.4 Spain Metagenomics Market by Application
8.6 Italy Metagenomics Market
8.6.1 Italy Metagenomics Market by Workflow
8.6.2 Italy Metagenomics Market by Product
8.6.3 Italy Metagenomics Market by Technology
8.6.4 Italy Metagenomics Market by Application
8.7 Rest of Europe Metagenomics Market
8.7.1 Rest of Europe Metagenomics Market by Workflow
8.7.2 Rest of Europe Metagenomics Market by Product
8.7.3 Rest of Europe Metagenomics Market by Technology
8.7.4 Rest of Europe Metagenomics Market by Application
Chapter 9. Company Profiles
9.1 Illumina, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Bio-Rad laboratories, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.3 Qiagen N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 Takara Bio, Inc. (Takara Holdings Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 PerkinElmer, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Oxford Expression Technologies Ltd.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Novogene Co., Ltd.
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.9.2.2 Geographical Expansions:
9.10. Promega Corporation
9.10.1 Company Overview
Unique Offerings 
